On the recordMarch 21, 2023
This manufacturing monopoly is one of the root causes of the drug shortage, and relying on China for active ingredients is a national security and public health risk.
Source
congress.govEditor's note · Context
Hassan highlights the risks of relying on foreign manufacturing for essential drugs.
Share
More from Maggie Hassan
Jun 25, 2026
Drug smuggling through ports of entry at the Southern border remains the primary mode by which fentanyl enters the United States.
Jul 10, 2026
Taxpayers should not be footing the bill for luxury personal travel for Trump Administration officials. These allegations of misuse of taxpayer dollars require oversight.
Jun 25, 2026
Your actions to provide the new weight-loss drug Retatrutide to one well-connected individual come as the Trump Administration has driven prescription drug costs for Americans through the roof.
Other voices in this conversation
